---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-087347"
form_type: "8-K"
ticker: "SEM"
cik: "0001320414"
company_name: "SELECT MEDICAL HOLDINGS CORP"
filed_at: "2023-08-03T23:59:59+00:00"
generated_at: "2026-06-12T07:26:42.628131+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Select Medical Q2 EPS $0.61 (+44% YoY), revenue up 5.7%; declares $0.125 dividend

## Summary
- Q2 revenue $1,674.5M (+5.7% YoY); net income $91.9M (+38.6% YoY); Adjusted EBITDA $219.5M (+21.3% YoY).
- Critical illness recovery hospital segment Adjusted EBITDA surged 227% to $65.5M; margin 11.4% vs 3.7%.
- Board declared $0.125/share cash dividend, payable Sep 1, 2023 to holders of record Aug 15.
- FY2023 outlook: revenue $6.55-6.7B, Adjusted EBITDA $795-825M, EPS $1.77-1.94, adjusted EPS $1.86-2.03.
- No shares repurchased in H1 2023; $1.0B buyback program expires Dec 31, 2023.

## SEC filing metadata
- accession: 0001104659-23-087347
- form_type: 8-K
- ticker: SEM
- cik: 0001320414
- company_name: SELECT MEDICAL HOLDINGS CORP
- filed_at: 2023-08-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1320414/000110465923087347/0001104659-23-087347-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1320414/000110465923087347/tm2322751d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-087347
- JSON: https://secwatch.observer/filing/0001104659-23-087347.json
- Plain text: https://secwatch.observer/filing/0001104659-23-087347.txt

## Key facts
- Earnings Releases
  SELECT MEDICAL HOLDINGS CORP reported second quarter ended June 30, 2023 results: revenue $1,674.5 million, net income $91.9 million, EPS $0.61.
  - Period: second quarter ended June 30, 2023
  - Revenue: $1,674.5 million
  - Net income: $91.9 million
  - EPS: $0.61
  - Result: reported results
  source text: For the second quarter ended June 30, 2023, revenue increased 5.7% to $1,674.5 million, compared to $1,584.7 million for the same quarter, prior year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1320414/000110465923087347/0001104659-23-087347-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.